Stroke and other vascular-related brain disorders remain leading causes of disability and death worldwide, making early intervention and specialized care essential. In managing these complex conditions, cerebrovascular experts play a central role by diagnosing and treating diseases that affect blood flow to the brain, including strokes, aneurysms, arteriovenous malformations (AVMs), and vascular dementia. These specialists use advanced imaging techniques, like CT angiography and MRIs, to assess the brain's vascular system and determine the best course of treatment. Whether through medication, minimally invasive procedures, or surgical intervention, their goal is to restore circulation and prevent further brain damage.
Often working in stroke centers or neurology departments, cerebrovascular experts collaborate with neurosurgeons, interventional radiologists, and critical care teams to manage acute emergencies and long-term care. They are also heavily involved in preventive medicine, helping patients control risk factors such as hypertension, diabetes, and high cholesterol. With the growing use of clot retrieval devices and thrombolytic therapy, their expertise continues to evolve alongside advances in neurovascular technology. In addition to clinical care, many are active in research focused on improving outcomes, reducing recurrence rates, and developing new protocols for faster response. Their specialized knowledge is vital for preserving brain function and saving lives in time-sensitive, high-stakes situations.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States